Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Book
|
Research of Pathogenesis and Novel Therapeutics in Arthritishttps://creativecommons.org/licenses/by-nc-nd/4.0/legalcode ;ISBN: 9783038970668 ;ISBN: 3038970662 ;ISBN: 9783038970651 ;ISBN: 3038970654 ;DOI: 10.3390/books978-3-03897-066-8Full text available |
|
2 |
Material Type: Article
|
Disease‐modifying anti‐rheumatic drugs for rheumatoid arthritis: a systematic review and network meta‐analysisCochrane database of systematic reviews, 2020-03, Vol.2020 (3) [Peer Reviewed Journal]Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD013562Full text available |
|
3 |
Material Type: Article
|
Long‐term glucocorticoids for rheumatoid arthritisCochrane database of systematic reviews, 2021-12, Vol.2021 (12) [Peer Reviewed Journal]Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD014899Full text available |
|
4 |
Material Type: Article
|
Correction: Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohortPloS one, 2019-04, Vol.14 (4), p.e0215198-e0215198 [Peer Reviewed Journal]COPYRIGHT 2019 Public Library of Science ;COPYRIGHT 2019 Public Library of Science ;2019 Gomides et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Gomides et al 2019 Gomides et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0215198 ;PMID: 30947308Full text available |
|
5 |
Material Type: Article
|
“To regain one’s health” – patients’ preferencesof treatment outcomes in early rheumatoid arthritis – a qualitative studyAnnals of the rheumatic diseases, 2019, Vol.78 (Suppl 2), p.648 [Peer Reviewed Journal]ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2019-eular.1408Full text available |
|
6 |
Material Type: Article
|
POS0860 COMPARING THE EFFICACY OF THE BDMARD SWITCHER GROUP AND JAK CYCLER GROUP IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH FAILURE TO THE JAK INHIBITORSAnnals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.734-735 [Peer Reviewed Journal]2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2023-eular.5422Full text available |
|
7 |
Material Type: Article
|
64; LATE-ONSET RHEUMATOID ARTHRITIS (OVER 60 YEARS OF AGE): CLINICAL, BIOLOGICAL, AND THERAPEUTIC FEATURES. ABOUT A RETROSPECTIVE STUDYAge and ageing, 2019-02, Vol.48, p.i17-i18 [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 0002-0729 ;EISSN: 1468-2834 ;DOI: 10.1093/ageing/afy214.01Full text available |
|
8 |
Material Type: Article
|
THU0667 Disease, work and personal related factors associated with presenteeism in patients with rheumatoid arthritis: results from the national rheumatoid arthritis society survey (NRAS)Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.527 [Peer Reviewed Journal]2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Copyright: 2018 © 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2018-eular.4121Full text available |
|
9 |
Material Type: Article
|
Correction: Is treat-to-target really working in rheumatoid arthritis? A longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)Annals of the rheumatic diseases, 2020-06, Vol.79 (6), p.e77-e77 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2019-216819corr1 ;PMID: 32434814Full text available |
|
10 |
Material Type: Article
|
250 The effect of JAK inhibition on neutrophil killing, netosis and metabolism in rheumatoid arthritisRheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.474Full text available |
|
11 |
Material Type: Article
|
087 Refractory disease in rheumatoid arthritis: results from the British Society of Rheumatology Biologics Register for rheumatoid arthritisRheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.311Full text available |
|
12 |
Material Type: Article
|
091 Insights into issues related to job loss in patients with rheumatoid arthritis: a UK national surveyRheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.315Full text available |
|
13 |
Material Type: Article
|
i053 The long-term complications of non-fatal rheumatoid arthritisRheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.053Full text available |
|
14 |
Material Type: Article
|
277 Online interventions for addressing psychological distress in people with rheumatoid arthritis and other long-term conditions: a systematic reviewRheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.501Full text available |
|
15 |
Material Type: Article
|
030 A crystal clear case of seropositive rheumatoid arthritisRheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.254Full text available |
|
16 |
Material Type: Article
|
241 Profiling rheumatoid arthritis biosimilar switchers: datafrom the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisRheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.465Full text available |
|
17 |
Material Type: Article
|
213 Factors associated with disability in rheumatoid arthritis patients with persistent moderate disease activityRheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.437Full text available |
|
18 |
Material Type: Article
|
e50 Biologic monotherapy in rheumatoid arthritis: a retrospective observational study of real life practice in the North WestRheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.591Full text available |
|
19 |
Material Type: Article
|
O07 Treating rheumatoid arthritis to target: is low disease activity good enough?Rheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.189Full text available |
|
20 |
Material Type: Article
|
242 A phase III randomised placebo-controlled double-blind study of upadacitinib (ABT-494), a selective JAK-1 Inhibitor, in patients with active rheumatoid arthritis with inadequate response to conventional synthetic DMARDsRheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3) [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2018 ;The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/key075.466Full text available |